ICU Management & Practice, Volume 18 - Issue 3, 2018
(I expert, I question, I answer)
Have you got something to say?
Visit https://healthmanagement.org/c/icu/list/blog or contact [email protected]![]() Jean Baptiste LascarrouMedical Intensive Care Unit, Nantes University Hospital, France Epinephrine for out-of-hospital cardiac arrest“Epinephrine (or adrenaline for EU physicians) has alpha-adrenergic action which leads to increased coronary blood flow but also beta-adrenergic action that can lead to the recurrence of VF/VT and can also impair cerebral microvascular blood flow. Additionally, recent data from randomised controlled trials on cardiogenic shock) or meta-analysis highlight poor outcome associated with epinephrine use. In this context, clinical trial of drug use with only “alpha-adrenergic” action such as norepinephrine deserves attention.” See more at: https://iii.hm/ns5 | |
![]() Pieter DepuydtHead of Clinic - Department of Intensive Care, Ghent University Hospital, BelgiumAntibiotic decisions in the ICU: a dragon’s taleSee more at: https://iii.hm/ns7
|



